http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0032595-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eeec33ab13c076b313531fe45d673b0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525
filingDate 1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed220490077497ab63fcb8d4bfda754
publicationDate 2000-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0032595-A1
titleOfInvention Process for the production of paroxetine hydrochloride acetone solvate
abstract Crystalline paroxetine hydrochloride acetone solvate having a modified habit that is more easily desolvated to form the anhydrate is obtained by crystallising from a solution of paroxetine hydrochloride in acetone to which has been added a habit modifier compound. Form A anhydrate is obtained by heating the crystalline solvate of modified habit in a vacuum oven. Suitable habit modifiers are carboxylic acids and amine salts.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0125230-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0125232-A1
priorityDate 1998-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0812827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0188081-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9624595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0223403-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9801424-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4007196-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136014265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9843029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127407860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232289957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57144289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823642

Total number of triples: 40.